Skip to content
Rio de Janeiro · São Paulo · Salvador — matters across Brazil
Bruno Marcelos — Escritório de Advocacia

Pauta Regulatória · Daily brief

No. 94

Automatically translated from the Portuguese edition, which prevails in case of discrepancy. Ler em português

Federal Official Gazette

No updates.

ANS news

DIDES begins 2026 Strategic Planning with technical team gathered

The Sector Development Directorate (DIDES) began its Strategic Planning for 2026 on the morning of Tuesday (Feb 24). The two-day immersion will be devoted to analyzing the unit’s main topics, with the aim of defining priorities that strengthen regulation and improve the services provided to society.

Open public consultations

  • CP 167. Subject: CP opened to collect criticism and suggestions regarding the preliminary recommendations contained in UAT No. 186 – Encorafenib, UAT No. 189 – Osimertinib and UAT No. 190 – Talazoparib. Deadline: Feb 10 to Mar 1.

Scheduled public hearings

There are no scheduled public hearings.

Open public calls for input

  • A Public Call for Input (TPS) is hereby opened to receive suggestions on the priority topics of Supplementary Health that will inform the composition of the 2026-2028 Regulatory Agenda of the National Supplementary Health Agency (ANS). Extension: February 27, 2026.

Open public calls

No updates.

Other news

The urgent need for a single criterion for high-cost drugs (attached)

Source: estadao.com.br · read the full article

CFM publishes opinion on autonomy in organizing medical schedules (attached)

Source: crmpr.org.br · read the full article

Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.